Adaptimmune Therapeutics (ADAPY) Enterprise Value History

Adaptimmune Therapeutics Plc (ADAPY)

0.03 +0.01 (+67.60%) USD | OTCM | Nov 11, 16:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2016. Start Trial.

Date	Value
November 11, 2026	30.57M
November 10, 2026	27.36M
November 09, 2026	29.11M
November 06, 2026	27.89M
November 05, 2026	27.63M
November 04, 2026	27.92M
November 03, 2026	29.25M
November 02, 2026	29.72M
October 30, 2026	28.72M
October 29, 2026	29.54M
October 28, 2026	30.23M
October 27, 2026	30.28M
October 26, 2026	29.27M
October 23, 2026	30.57M
October 22, 2026	29.25M
October 21, 2026	31.10M
October 20, 2026	31.23M
October 19, 2026	31.90M
October 16, 2026	31.10M
October 15, 2026	31.45M
October 14, 2026	30.57M
October 13, 2026	30.17M
October 12, 2026	30.57M
October 09, 2026	30.57M
October 08, 2026	30.04M

Date	Value
October 07, 2026	30.01M
October 06, 2026	30.31M
October 05, 2026	30.57M
October 02, 2026	32.43M
October 01, 2026	32.69M
September 30, 2026	32.69M
September 29, 2026	29.51M
September 28, 2026	29.72M
September 25, 2026	29.38M
September 24, 2026	28.72M
September 23, 2026	29.51M
September 22, 2026	29.59M
September 21, 2026	29.67M
September 18, 2026	28.58M
September 17, 2026	28.72M
September 16, 2026	29.25M
September 15, 2026	29.25M
September 14, 2026	28.98M
September 11, 2026	28.62M
September 10, 2026	28.75M
September 09, 2026	29.25M
September 08, 2026	29.51M
September 04, 2026	29.72M
September 03, 2026	29.51M
September 02, 2026	29.25M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks